|
PPP2R5E expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.16729999999998E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.57069999998194E-06 |
| Normal-vs-Stage2 |
2.475500E-02 |
| Normal-vs-Stage3 |
2.693600E-01 |
| Normal-vs-Stage4 |
5.220100E-02 |
| Stage1-vs-Stage2 |
7.784800E-01 |
| Stage1-vs-Stage3 |
1.350560E-01 |
| Stage1-vs-Stage4 |
9.734400E-01 |
| Stage2-vs-Stage3 |
4.411800E-01 |
| Stage2-vs-Stage4 |
8.738200E-01 |
| Stage3-vs-Stage4 |
4.608600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.20800000000554E-05 |
| Normal-vs-AfricanAmerican |
2.837200E-04 |
| Normal-vs-Asian |
3.753900E-02 |
| Caucasian-vs-AfricanAmerican |
7.422600E-01 |
| Caucasian-vs-Asian |
9.448000E-01 |
| AfricanAmerican-vs-Asian |
9.606400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.49910000261045E-08 |
| Normal-vs-Female |
6.838800E-01 |
| Male-vs-Female |
3.609000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.204050E-03 |
| Normal-vs-Extreme_Weight |
2.79590000040741E-07 |
| Normal-vs-Obese |
8.717800E-02 |
| Normal-vs-Extreme_Obese |
4.360500E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.493200E-01 |
| Normal_Weight-vs-Obese |
1.833590E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.103600E-01 |
| Extreme_Weight-vs-Obese |
1.960040E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.630400E-01 |
| Obese-vs-Extreme_Obese |
3.316400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.638200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.155000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.3442000001973E-07 |
| Normal-vs-Age(81-100Yrs) |
9.54360000027243E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.260000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.867700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.538200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.599730E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.759700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.183600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.00209999976242E-07 |
| Normal-VS-Type2 PRCC |
3.7484000000032E-05 |
| Normal-VS-KIRP CIMP |
1.912220E-01 |
| Normal-VS-Unclassified PRCC |
1.769030E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.821600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.849800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.122400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.014000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.222590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.874100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.1861999994518E-07 |
| Normal-vs-N1 |
8.675600E-01 |
| Normal-vs-N2 |
1.640660E-03 |
| N0-vs-N1 |
1.712260E-02 |
| N0-vs-N2 |
6.037600E-01 |
| N1-vs-N2 |
1.900570E-01 |
|
|
